We’re excited to share that our Comprehensive Panel with Analyte Assurance™, as well as the below referenced panels, have been updated in all orders effective June 2nd, 2025. The analytes that have been added are as follows:

• ortho-Methylfentanyl – Confirmed via Designer Opioids Panel
• N-Cyclohexyl Methylone – Confirmed via Novel Psychoactive Substances Panel
• N-Isopropyl Butylone – Confirmed via Novel Psychoactive Substances Panel
• Tizanidine – Confirmed via Novel Emerging Compounds Panel

These analytes are now included as part of Analyte Assurance™, meaning that if any of these analytes are presumptively positive, our Lab Client Support team will contact you to determine whether further confirmatory testing is desired.

At Axis Forensic Toxicology, we prioritize your needs and continuously work to improve our services to better meet your expectations. These new additions are a direct result of your input and our dedication to providing you with the most complete and reliable testing solutions.

If you have any questions or need further information about this update, please don’t hesitate to contact us at [email protected]. Our team is always ready to assist you.

Thank you for your continued trust and partnership. We look forward to delivering the highest quality service and testing solutions to support your needs.

Sincerely,
Matt Zollman
Director of Operations & Product Management